6/2010
Our nano-particle-based TRUESolutionTM compound formulation/solubilization technology is to become available to BIOAXXESS® network members as a fee-for-service. Current RUO targets include; NFkappaB inhibitors, polyphenol anti-oxidants, NKT-cell activators. Please enquire.
3/2010
BIOAXXESS® Bacteriomimics immunisation adjuvant technology yield high antibody titer also against challenging non-immunogenic antigens, such as those that are highly conserved.